Work

PDL1 landscape in checkpoint inhibitor ineligible patients by IHC and cfRNA.

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.15_suppl.e14570

Authors: Shumei Kato, Noor Khalid, Rebecca Jimenez, Suzanna Lee, Leylah Drusbosky, Christopher Szeto, Chad Garner, Sandeep K. Reddy, Razelle Kurzrock

Institutions: University of California San Diego, Moores Cancer Center, NantOmics LLC (United States)

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2947672721

Cites:

Cited by:

Related to: 10